Reuters logo
BRIEF-Titan Pharma receives FDA clearance to begin clinical study of Parkinson's disease treatment
2017年8月24日 / 上午11点09分 / 1 个月前

BRIEF-Titan Pharma receives FDA clearance to begin clinical study of Parkinson's disease treatment

Aug 24 (Reuters) - Titan Pharmaceuticals Inc

* Titan Pharmaceuticals receives fda clearance to begin clinical study of Parkinson’s disease treatment Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below